axialHealthcare Announces $15 Million in Series C Funding to Support Expansion into Substance Use Disorder Treatment and Recovery Sector NASHVILLE, Tenn., February 27, 2020-- axialHealthcare, a care optimization company navigating substance use issues for patients, providers, and health plans, today announced it has closed $15 million in equity financing to accelerate its expansion into the substance use disorder (SUD) treatment and recovery sector, led by previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund.